StreetInsider.com News Articles

Form S-1 CTT PHARMACEUTICAL HOLDI

Tue, 30 Dec 2025 16:16:00 -0500

si-local-file:///var/storage/secattach/20251230/25791138.html

Form S-1 CTT PHARMACEUTICAL HOLDI

Tue, 30 Dec 2025 16:16:00 -0500

si-local-file:///var/storage/secattach/20251230/25791138.html

CTT Pharmaceutical files S-1 registration, expands credit line to $10 million

Tue, 30 Dec 2025 06:01:39 -0500

CTT Pharmaceutical Holdings, Inc. (OTCQB: CTTH) filed a Form S-1 registration statement with the Securities and Exchange Commission, the company announced December 30. The filing represents part of the company's transition to fully reporting status.

The Tampa-based pharmaceutical technology company also expanded its equity line of credit from $3 million to $10 million through an agreement with RH2 Equity Partners. The company stated the increased funding will support commercialization initiatives and help scale future product lines.

CTT Pharmaceutical develops thin film oral drug delivery systems using what it describes as patented micelle-based technology. The company received approval for publication of a peer-reviewed

CTT Pharmaceutical files S-1 registration, expands credit line to $10 million

Tue, 30 Dec 2025 06:01:39 -0500

CTT Pharmaceutical develops thin film oral drug delivery systems using what it describes as patented micelle-based technology. The company received approval for publication of a peer-reviewed

CTT Pharmaceutical Holdings, Inc. Files Form S-1 Registration Statement and Advances Equity Line of Credit and Scientific Development Milestones

Tue, 30 Dec 2025 06:00:00 -0500

TAMPA, FL / ACCESS Newswire / December 30, 2025 / CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) today announces the filing of a Form S-1 registration statement with the United States Securities and Exchange Commission. The filing marks an important milestone in the Company's transition to fully reporting status and reflects management's commitment to regulatory transparency, operational discipline, and long-term corporate development. The Company also continues to advance its initial $3,000,000 Equity Line of Credit, which provides strategic financial flexibility to support commercialization initiatives and ongoing scientific progress. Additionally, CTT and RH2 Equity Partners

CTT Pharmaceutical Holdings, Inc. Files Form S-1 Registration Statement and Advances Equity Line of Credit and Scientific Development Milestones

Tue, 30 Dec 2025 06:00:00 -0500

Form 4 CTT PHARMACEUTICAL HOLDI For: Dec 15 Filed by: CTT PHARMACEUTICAL HOLDINGS, INC.

Wed, 17 Dec 2025 11:46:00 -0500

si-local-file:///var/storage/secattach/20251217/25751670.html

Form 4 CTT PHARMACEUTICAL HOLDI For: Dec 15 Filed by: CTT PHARMACEUTICAL HOLDINGS, INC.

Wed, 17 Dec 2025 11:46:00 -0500

si-local-file:///var/storage/secattach/20251217/25751670.html

CTT Pharma scientists publish research on drug delivery technology

Tue, 16 Dec 2025 06:01:07 -0500

CTT Pharmaceutical Holdings Inc. (OTCQB: CTTH) announced that its scientists published a peer-reviewed paper in the Journal of Drug Delivery and Therapeutics. The article was authored by Dr. Katharine Cole and Dr. Pankaj Modi, who founded CTT Pharma.

The publication describes micellar nanotechnology combined with oral dissolvable strip delivery systems for therapeutic compounds. According to the company, the paper represents the first comprehensive scientific review of this technology approach.

"This review article is an important step forward in bringing wider scientific attention to this innovative and transformative technology," Dr. Cole stated.

The Tampa, Florida-based company made the publication available on its website in

CTT Pharma's Scientists Publish Peer-Reviewed Paper in the Journal of Drug Delivery and Therapeutics

Tue, 16 Dec 2025 06:00:00 -0500

TAMPA, FL / ACCESS Newswire / December 16, 2025 / (OTCQB:CTTH) CTT Pharmaceutical Holdings, Inc. is pleased to announce that a peer-reviewed scientific paper has been published in the journal of Drug Delivery and Therapeutics, authored by our scientist Dr. Katharine Cole and Dr. Pankaj Modi, the founder of CTT Pharma. The article provides the first comprehensive scientific review describing how micellar nanotechnology, when combined with an oral dissolvable strip delivery system, can significantly improve the delivery and bioavailability of active therapeutic compounds. "This review article is an important step forward in

CTT Pharma's Scientists Publish Peer-Reviewed Paper in the Journal of Drug Delivery and Therapeutics

Tue, 16 Dec 2025 06:00:00 -0500

Form 4 CTT PHARMACEUTICAL HOLDI For: Nov 20 Filed by: CTT PHARMACEUTICAL HOLDINGS, INC.

Mon, 24 Nov 2025 13:19:00 -0500

si-local-file:///var/storage/secattach/20251124/25654719.html

Form 4 CTT PHARMACEUTICAL HOLDI For: Nov 20 Filed by: CTT PHARMACEUTICAL HOLDINGS, INC.

Mon, 24 Nov 2025 13:19:00 -0500

si-local-file:///var/storage/secattach/20251124/25654719.html

Form 4 CTT PHARMACEUTICAL HOLDI For: Nov 20 Filed by: CTT PHARMACEUTICAL HOLDINGS, INC.

Fri, 21 Nov 2025 09:41:00 -0500

si-local-file:///var/storage/secattach/20251121/25647679.html

Form 4 CTT PHARMACEUTICAL HOLDI For: Nov 20 Filed by: CTT PHARMACEUTICAL HOLDINGS, INC.

Fri, 21 Nov 2025 09:41:00 -0500

si-local-file:///var/storage/secattach/20251121/25647679.html

Form 4 CTT PHARMACEUTICAL HOLDI For: Oct 10 Filed by: CTT PHARMACEUTICAL HOLDINGS, INC.

Fri, 31 Oct 2025 09:48:00 -0500

si-local-file:///var/storage/secattach/20251031/25535328.html

Form 4 CTT PHARMACEUTICAL HOLDI For: Oct 10 Filed by: CTT PHARMACEUTICAL HOLDINGS, INC.

Fri, 31 Oct 2025 09:48:00 -0500

si-local-file:///var/storage/secattach/20251031/25535328.html

Form 4 CTT PHARMACEUTICAL HOLDI For: Sep 23 Filed by: CTT PHARMACEUTICAL HOLDINGS, INC.

Tue, 07 Oct 2025 11:55:00 -0500

si-local-file:///var/storage/secattach/20251007/25429042.html

Form 4 CTT PHARMACEUTICAL HOLDI For: Sep 23 Filed by: CTT PHARMACEUTICAL HOLDINGS, INC.

Tue, 07 Oct 2025 11:55:00 -0500

si-local-file:///var/storage/secattach/20251007/25429042.html

Form 4 CTT PHARMACEUTICAL HOLDI For: Aug 01 Filed by: CTT PHARMACEUTICAL HOLDINGS, INC.

Tue, 23 Sep 2025 10:52:00 -0500

si-local-file:///var/storage/secattach/20250923/25364893.html

Form 4 CTT PHARMACEUTICAL HOLDI For: Aug 01 Filed by: CTT PHARMACEUTICAL HOLDINGS, INC.

Tue, 23 Sep 2025 10:52:00 -0500

si-local-file:///var/storage/secattach/20250923/25364893.html

Form 4 CTT PHARMACEUTICAL HOLDI For: Jun 30 Filed by: CTT PHARMACEUTICAL HOLDINGS, INC.

Fri, 01 Aug 2025 16:51:00 -0500

si-local-file:///var/storage/secattach/20250801/25137408.html

Form 4 CTT PHARMACEUTICAL HOLDI For: Jun 30 Filed by: CTT PHARMACEUTICAL HOLDINGS, INC.

Fri, 01 Aug 2025 16:51:00 -0500

si-local-file:///var/storage/secattach/20250801/25137408.html

Form 4 CTT PHARMACEUTICAL HOLDI For: Jun 27 Filed by: CTT PHARMACEUTICAL HOLDINGS, INC.

Tue, 08 Jul 2025 13:05:00 -0500

si-local-file:///var/storage/secattach/20250708/25028145.html

Form 4 CTT PHARMACEUTICAL HOLDI For: Jun 27 Filed by: CTT PHARMACEUTICAL HOLDINGS, INC.

Tue, 08 Jul 2025 13:05:00 -0500

si-local-file:///var/storage/secattach/20250708/25028145.html